Since it has been also shown that GSK-3β regulates tumor cell survival through a NF-κB-dependent pathway [7], [30] we next tested whether GSK-3β inhibition by TDZD-8 could affect NF-κB activity in GL261 cells. This evidence concerns the gene GSK3B and neoplasm.